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Abstract
Background: This study investigated the prevalence for hepatitis A virus (HAV), hepatitis E virus (HEV), herpes simplex 
virus type 2 (HSV2) and syphilis among homeless in the city of Tehran.
Methods: In this cross-sectional study, 596 homeless were recruited in Tehran. A researcher-designed questionnaire was 
used to study demographic data. Using enzyme-linked immunoassay, and rapid plasma reagin (RPR) test, we evaluated 
the seroprevalence of HAV anti-body, HEV IgG, herpes, HSV2 IgG, and syphilis among sheltered homeless in Tehran. 
The associations between the participant’s characteristics and infections were evaluated using logistic regression and 
chi-square.
Results: A total of 569 homeless, 78 women (13.7%) and 491 men (86.3%) were enrolled into the study from June to 
August 2012. Their age mean was 42 years and meantime of being homeless was 24 months. Seroprevalence of syphilis, 
HEV IgG, HSV2 IgG and HAV Ab was 0.55%, 24.37%, 16.48%, and 94.34%, respectively. History of drug abuse was 
reported in 77.70%; 46.01% of them were using a drug during the study and 26.87% of them had history of intravenous 
drug abuse. Among people who had intravenous drug abuse, 48.25% had history of syringe sharing. 
Conclusion: The prevalence of HAV, HEV and HSV2 were higher than the general population while low prevalence of 
syphilis was seen among homeless peoples who are at high risk of sexually transmitted infection (STD). Our findings 
highlighted that significant healthcare needs of sheltered homeless people in Tehran are unmet and much more attention 
needs to be paid for the health of homeless people.
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Implications for policy makers
• Homeless people are those who have no place to sleep and sleep in public or private shelters. They are including mental health disorders, 
alcoholics and mostly injecting drug users, and immigrants.
• Homeless people are also at higher risk than the general population for viral hepatitis and syphilis due to social and behavioral factors that 
influence the occurrence of these diseases. 
• Overcrowded shelters, poor living conditions and limited access to healthcare systems, expose homeless persons to communicable infections, 
which may spread among them leading serious public health concerns. 
Implications for the public
Our findings highlighted that significant healthcare needs of sheltered homeless people in Tehran are unmet and much more attention needs to be 
paid for the health of homeless people. The risks of infectious disease outbreaks in homeless populations are significantly higher than those in the 
general population. These increased risks are a public health challenge for the population as a whole. Implementation of specific strategies to reduce 
these risks is crucial.
Key Messages 
Introduction
Homeless includes people who have no place to sleep and 
sleep in public or private shelters. They are including mental 
health disorders, alcoholics1 and in Iran, mostly injecting 
drug users, and immigrants.2 The life expectancy of homeless 
people is much shorter than the general population, and rates 
of infectious diseases are higher among them.3 High risks of 
infectious diseases among homeless people are related to their 
living condition, poor sanitation and living within the group 
that makes them susceptible to many communicable diseases, 
outbreaks of HIV, tuberculosis, and viral hepatitis have been 
reported among them in many countries.1,3,4 Homeless people 
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are also at higher risk than the general population for viral 
hepatitis and syphilis due to social and behavioral factors that 
influence the occurrence of these diseases.5-7
Homeless people are at high risk for viral hepatitis (A, B, and 
C) because their lifestyles might include injection drug use 
(IDU) and poor hygiene, but data on hepatitis E virus (HEV) 
and hepatitis A virus (HAV) prevalence among them are 
limited.7-9
Syphilis and herpes simplex virus type 2 (HSV2) are common 
sexually transmitted infections (STDs).10,11 Treponema 
pallidum infects at least 12 million persons annually. HSV2 
seropositive persons have a lifelong risk of infecting their 
sexual partners.12 Genital ulcer disease due to both syphilis 
and HSV2 is associated with an increased risk of obtaining 
HIV.11 Findings of a previous study among homeless people 
of this study showed a high prevalence of HIV among them.7
There is no precise estimate on the number of homeless 
people and the rate of their risky behaviors in Iran. Due to 
a lack of updated information on infectious diseases, and 
the absence of a study on the situation of infectious diseases 
among homeless people in Iran, the aim of this study was to 
investigate the prevalence of HAV, HEV, HSV2 and syphilis 
among sheltered adult homeless people in Tehran and 
to evaluate the high-risk behaviors associated with these 
infections among them.
Methods
This study was conducted in Tehran, the capital of Iran, from 
June to August 2012. 
Participants were recruited from five centers working under 
the authority of the municipality. Homeless people were 
eligible to participate in the study if they were 18–60 years 
old and had been continuously or discontinuously homeless 
(during the month prior to the study period) for at least 10 
days.13
A homeless person was defined as someone who had no home 
or shelter to reside in, and instead resided on the corners of 
streets, in parks, or in public places, if there was no designated 
residence provided by governmental or non-governmental 
organizations. 
In this study, verbal informed consent was provided. This 
form included descriptions of voluntary participation and the 
incentives for participating in the study. A researcher-made 
questionnaire was used to assess the behaviors. 
Blood samples were tested to detect HAV antibody (Ab), 
hepatitis E IgG (HEV IgG) and HSV2 IgG, using commercially 
available ELISA kits (Dia.Pro Diagnostic BioProbes srl, Italy) 
and rapid plasma reagin (RPR) test for syphilis.
Data analysis was carried out by SPSS (version 16, SPSS Inc., 
Chicago, IL, USA) software package. Associations between 
participants’ characteristics and the infections were evaluated 
using logistic regression and chi-square test. P values less than 
0.05 were considered statistically significant. 
Results
A total of 569 homeless, 78 women (13.08%) and 491 men 
(82.38%) were enrolled into the study from five centers in 
Tehran during June to August 2012. Their age mean was 
42 years and meantime of being homeless was 24 months. 
History of drug abuse among homeless people was 77.70%, 
46.01% of them were using a drug during study and 26.87% of 
them had history of intravenous drug abuse. Among people 
who had intravenous drug abuse, 48.25% had history of 
syringe sharing.
Seroprevalence of syphilis (among 542 tested homeless) was 
0.55%, HEV IgG (among 562 tested homeless) was 24.37%, 
HSV2 IgG (among 546 tested homeless) was 16.48%. History 
of sexual contact (legal or illegal) was seen among 80.00% of 
the participants; of these, only 33.86% used condom in last 
sexual contact. History of either selling sex or having sex with 
other men was seen among 14 women (21.87%) and 36 men 
(9.30%), respectively.
Univariate analysis showed no significant correlation between 
seroprevalence of syphilis and HSV-2. There was a significant 
positive association between HAV, HEV seroprevalence and 
age. Prevalence of HAV significantly was higher in men. 
Education level had significant relation with HEV; HEV 
prevalence among people with higher level of education was 
lower than those who have low education (Table). 
Discussion
Finding of this study showed moderately high seroprevalence 
of HEV (24.37%) and high seroprevalence of HAV 
amongst homeless people of Tehran, with almost near to 
all of participants (94.34%) having HAV IgG. Although 
syphilis seroprevalence in this study was not high (0.55%.), 
nevertheless, the high prevalence of IDUs (20.73%), and 
needle sharing (10.72%) between Tehran homeless people can 
serve as a warning for future blood borne epidemics among 
homeless people who are also intravenous drug users. 
Sexually transmitted infections (STIs) that cause open 
sores on the genitals, like herpes and syphilis can increase 
HIV transmission.14 HSV-2 increases susceptibility to HIV 
infection through physical disruption of the epithelial surface 
by HSV-2, and recruitment and persistence of inflammatory 
cells in the genital tract during HSV-2 reactivation at mucosal 
surfaces.14 Genital herpes, caused by the HSV-2, is one of the 
most common sexually transmitted infections worldwide. 
Prevalence of HSV-2 IgG in northern Iran was reported 
3.5% among general population, and significant correlation 
was seen between age, marital status, job, symptoms, and 
history of disease and HSV-2 seroprevalence.15 Surprisingly, 
in contrast with Noell et al study,8 there was no correlation 
between inconsistent condom use and HSV2 seroprevalence 
in this study. The prevalence of HSV2 among homeless 
people in the present study is higher than its prevalence in the 
general population, even higher than the prevalence reported 
by other studies.9,10 This can be attributed to the poor sexual 
health of the targeted homeless in compare with the general 
population which is line with higher prevalence of HIV 
prevalence among them.7
The overall prevalence of syphilis is relatively low in Iran. 
The reported prevalence in the most studies was limited to 
0.2% to 0.6%.16 The prevalence of syphilis in blood donors 
in Tehran province between 2005 to 2011 was reported 
10.5 per 100 000 donation.17 The findings of studies among 
adolescence and street children in Tehran,18-20 are compatible 
with the findings of the present study, three individuals out of 
542 sera had reactive RPR test and seroprevalence of syphilis 
was 0.55%. The prevalence of syphilis among the other 
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Table. Univariate Analysis of Factors Associated With the Prevalence of HAV, HEV, HSV2 and Syphilis on Homeless People in Tehran, 2012
Variables Categories RPR OR  (95% CI) HAV OR  (95% CI) HEV OR  (95% CI) HSV2 OR  (95% CI)
Age*
More than 42 year 261 (1.15)
0.61 (0.02-8.07)
258 (98.06)
5.44 (5.05-14.39)
265 (35.47)
3.27 (2.16-4.96)
260 (16.54)
1.04 (0.65-1.64)
Less than 42 years 269 (0.00) 268 (90.30) 285 (14.39) 274 (16.06)
Gender
Female 78 (0.00)
0.61 (0.02-8.07)
78 (84.62)
4.22 (1.96-9.09)
484 (25.62)
1.72 (0.92-3.23)
468 (15.60)
0.66 (0.37-1.20)
Male  464 (0.64) 460 (95.87) 78 (16.17) 78 (21.79)
Educational level
Illiterate 65 (0.00) - 66 (100.00) - 67 (40.30) Reference 66 (16.67) Reference
Literate 28 (0.00) - 28 (100.00) - 28 (46.43) 1.28 (0.53-3.12) 28 (21.43) 1.36 (0.45-4.14)
Primary school 105 (1.90) - 103 (95.15) - 110 (30.91) 0.66 (0.35-1.25) 105 (19.05) 1.18 (0.52-2.65)
Secondary school 142 (0.00) - 143 (95.10) - 149 (18.12) 0.33 (0.17-0.62) 146 (14.38) 0.84 (0.38-1.86)
High school 143 (0.70) - 139 (90.45) - 143 (16.78) 0.30 (0.16-0.58) 139 (15.11) 0.89 (0.40-1.97)
Academic level 44 (0.00) - 43 (86.05) - 48 (16.67) 0.30 (0.12-0.73) 46 (15.22) 0.90 (0.32-2.52)
Duration of being Homelessa
More than 24 months 233 (0.43)
0.61 (0.02-8.07)
232 (93.66)
0.99 (0.48-2.07)
240 (25.83)
1.16 (0.78-1.72)
232 (15.94)
0.91 (0.57-1.45)
Less than 24 months 285 (0.70) 282 (93.97) 298 (23.15) 290 (17.24)
History of Drug use
Yes 412 (0.73)
4.88 (0.42-163.20)
409 (94.13)
1.05 (0.44-2.50)
433 (23.56)
1.26 (0.81-1.98)
417 (15.35)
1.38 (0.83-2.30)
No 126 (0.00) 125 (94.40) 125 (28.00) 125 (20.00)
Drug use  (currently)
Yes 180 (0.56)
0.64 (0.02-8.51)
175 (92.00)
1.95 (0.84-4.50)
200 (24.00)
0.96 (0.61-1.49)
185 (18.92)
0.61 (0.36-1.05)
No 232 (0.86) 234 (95.73) 233 (23.18) 232 (12.50)
Kind of Drug Use
Hashish
Yes 11 (0.00)
25.11 (0.51-1274)
10 (100.00)
1.43 (0.17-42.76)
11 (45.45)
2.83 (0.82-9.73)
10 (10.00)
0.46 (0.06-3.76)
No 169 (0.59) 165 (91.51) 189 (24.34) 175 (19.42)
Kerackb
Yes 41 (0.00)
5.54 (0.11-266.30)
40 (90.00)
0.72 (0.21-2.43)
53 (22.64)
0.90 (0.43-1.90)
43 (16.28)
0.79 (0.32-1.97)
No 139 (0.72) 135 (92.59) 147 (24.29) 142 (19.72)
Heroin
Yes 60 (0.00)
3.27 (0.07-156.60)
57 (92.98)
1.23 (0.37-4.10)
67 (28.36)
1.42 (0.73-2.78)
60 (18.33)
0.95 (0.43-2.08)
No 120 (0.83) 118 (93.22) 133 (21.80) 125 (19.20)
Methamphetamine
Yes 80 (1.25)
2.04 (0.04-97.87)
75 (92.00)
1.01 (0.34-3.05)
90 (20.00)
0.66 (0.34-1.28)
80 (22.50)
1.60 (0.76-3.37)
No 99 (0.00) 99 (91.92) 109 (27.52) 104 (15.38)
Opium
Yes 60 (0.00)
0.83 (0.02-36.63)
57 (94.74)
1.85 (0.50-6.91)
70 (22.86)
0.91 (0.46-1.80)
60 (13.33)
0.56 (0.24-1.32)
No 120 (0.83) 118 (90.68) 130 (24.42) 125 (21.60)
Others
Yes 11 (0.00)
0.11 (0.01-5.48)
10 (90.00)
0.77 (0.09-6.56)
12 (41.67)
2.41 (0.73-7.97)
11 (90.90)
0.41 (0.05-3.33)
No 169 (0.59) 165 (92.12) 188 (22.87) 174 (19.54)
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Injecting drugs
Yes 303 (0.33)
0.54 (0.01-25.60)
101 (93.07)
0.87 (0.35-2.14)
113 (25.66)
1.10 (0.67-1.81)
103 (15.53)
0.89 (0.48-1.64)
No 99 (0.00) 297 (93.94) 310 (23.87) 304 (17.11)
Sharing needle
Yes 49 (0.00)
-
51 (92.16)
0.76 (0.14-3.91)
58 (29.31)
1.45 (0.62-3.41)
52 (13.46)
0.71 (0.24-2.08)
No 49 (0.00) 49 (93.88) 54 (22.22) 50 (18.00)
Age at the start of injecting drug
43 (0.00)
-
44 (95.45)
1.79 (0.31-10.26)
49 (26.53)
1.04 (0.44-2.46)
44 (15.91)
1.06 (0.35-3.21)
50 (0.00) 51 (92.16) 58 (25.86) 53 (15.09)
History of Incarceration 
Never 273 (1.09) - 271 (93.36) Reference 281 (25.53) Reference 273 (17.94) Reference
More than 10 years ago 64 (0.00) - 62 (96.77) 2.13 (0.48-9.45) 65 (24.61) 0.97 (0.52-1.81) 62 (17.74) 0.99 (0.48-2.03)
Recent 10 years 194 (0.00) - 194 (94.33) 1.18 (0.55-2.57) 205 (23.41) 0.90 (0.59-1.38) 200 (14.00) 0.74 (0.45-1.23)
Duration of Incarceration  (in last 
10 years)a
Upper than 11 months 95 (0.00)
-
95 (93.68)
0.79 (0.24-2.71)
101 (28.71)
1.88 (0.97-3.66)
98 (13.27)
0.88 (0.39-1.95)
Lower than 11 months 98 (0.00) 98 (94.90) 102 (17.65) 101 (14.85)
History of having sex
Yes 429 (0.47)
0.48 (0.04-5.37)
424 (93.63)
0.58 (0.20-1.70)
441 (24.72)
1.09 (0.67-1.77)
429 (16.62)
0.77 (0.45-1.32)
No 104 (0.96) 105 (96.19) 112 (23.21) 108 (19.44)
Condom use at last sexual 
encounter
Yes 145 (0.00)
1.28 (0.04-19.87)
141 (90.07)
0.44 (0.20-0.96)
147 (22.45)
0.82 (0.52-1.31)
144 (12.50)
0.68 (0.38-1.22)
No 282 (0.71) 281 (95.37) 292 (26.03) 283 (17.31)
Sex work  (female)
Yes 14 (0.00)
-
14 (78.57)
2.14 (0.46-9.90)
14 (7.14)
3.90 (0.46-32.94)
14 (14.28)
1.26 (0.24-6.61)
No 52 (0.00) 53 (88.68) 52 (23.08) 52 (17.31)
Men who have sex with men
Yes 32 (0.00)
6.64 (0.20-104.60)
32 (87.50)
3.34 (1.02-10.93)
33 (24.24)
1.06 (0.46-2.44)
32 (18.75)
0.72 (0.28-1.85)
No 321 (0.62) 317 (95.90) 332 (25.30) 322 (14.29)
Abbreviations: HAV, hepatitis A virus; HEV, hepatitis E virus; HSV2, herpes simplex virus type 2.
a Median of the variable is used for analysis; b A purified and potent form of heroin (not to be mistaken with crack cocaine).
Table. Continued
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high-risk group like female sex-worker in Kerman, south-
east Iran and Shiraz was 7.2% and 0.278% respectively.21,22 
The high prevalence of HIV,7 HSV2 and low prevalence of 
syphilis in the present study and overall in Iran indicates 
that syphilis infection is not prevalent in Iran, even among 
high-risk population. Prevalence of syphilis in Brazil was 
reported 7.0% among homeless.23 No significant association 
was found between high-risk sexual behavior and syphilis. 
Sheltered homeless people in Tehran are living in a situation 
relatively similar to prisons. Overcrowded sheltered, low 
personal and environment hygiene and exposed to high-risk 
behaviors, all together make them vulnerable to infectious 
disease, particularly sexually transmitted disease. Although 
syphilis seems not to be significant infectious diseases among 
homeless in Tehran but due to high rate of sexual and drug-
related behaviors, they may be at a higher risk in the future. 
Even though the prevalence of syphilis is low among the 
studied people, the surveillance of this disease should be 
continued throughout the country. 
Among the study population 94.34% were found HAV 
seropositive. HAV is an endemic disease in Iran and is highly 
prevalent across the country. Its seroprevalence in the general 
population of Tehran24 and Fars25 was reported 90% and 
88.2%, respectively. Similar to this study, HAV seroprevalence 
was higher among men and older ages. Other anti-HAV 
seroprevalence studies among homeless people conducted 
in Australia, Canada and San Francisco in the United States 
found similarly high anti-HAV prevalence of 48%, 53% and 
2%, respectively. Like the present study, these studies found 
older age to be a major predictor of anti-HAV.
This work showed that the seroprevalence of HEV was 
moderately high (24.37%) in homeless people. Similar to the 
studies previously have done in Iranian general population 
on blood donors, the prevalence of HEV IgG in homeless 
persons was lower among younger people with higher level 
of education24,26 and no differences in gender. To the best of 
our knowledge, seroprevalence of HEV in Iranian homeless 
has never been reported up to now. Based on this study, the 
HEV seroprevalence in Iranian homeless was much higher 
than what have seen in Los Angeles (13.6)27 and Marseille in 
France (11.6%).7 HEV seroprevalence in general population 
of Tehran (9.3%)24 and Isfahan (3.8%)26 was much lower than 
this study. The prevalence of HAV and HEV in this study is 
higher than the prevalence observed in the general population 
of the country. This finding suggests that homelessness 
increases the risk of being HAV and HEV positive. 
Several limitations in this study must be noted. First, all data 
are from self-reports. Second, because of lifestyles that are 
extremely transient and sometimes cryptic, it is impossible 
to obtain a truly representative sample of “homeless” and 
generalizations to all homeless populations are not possible. 
However, the relatively large size of the sample gives some 
confidence that these data are applicable to the more visible 
part of the homeless population in Tehran. Third, in this 
study RPR test was used to screen sera for Syphilis. RPR test 
is a non treponemal antibody test, although these screening 
tests are non-specific, it has traditionally been used for initial 
syphilis screening due to their relative low-cost and ease of 
performance. The other restriction is lack of enough samples 
for all tests in some cases. Since this study was conducted after 
our main study, to check the vulnerability of homeless people 
to HIV, Tuberculosis and viral hepatitis, some of the blood 
samples were not adequate for present study.13 Actually present 
study was a secondary data analysis; therefore, questioner 
and sampling have not designed for these disease and tests. 
Accordingly, some questions and high-risk behavior which 
could be helpful in the final analysis have not been asked.
Another limitation of the study was that pathogen infection 
was determined based on seropositivity to IgG antibodies. 
IgG antibodies reflect prior infection, but are not sensitive 
indicators of current infection. For instance, it is likely the 
high sero-prevalence of HAV reflect exposure to this virus in 
early childhood (as it is common in most low and middle-
income settings), rather than current infection, and as such 
not a risk for potential onward transmission. A similar thing 
may be said with regards to syphilis, as low titers of RPR may 
be remained for long periods (or be prone to false positive 
results). Unfortunately, our data are unable to address this 
issue. Notably, IgG antibodies were used to define infection in 
most studies among homeless people.4,6,7,13,19,23
In conclusion, overcrowded sheltered, poor living conditions 
and limited access to healthcare systems, exposes homeless 
persons to communicable infections, which may spread 
among them and lead serious public health concerns. The 
risks of infectious disease outbreaks in homeless populations 
are significantly higher than those in the general population. 
These increased risks are a public health challenge for the 
population as a whole. Implementation of specific strategies 
to reduce these risks is crucial. According to the result of this 
study, the necessity of implementing preventive programs is 
recommended. Educational programs, counseling and testing 
of transmission of infection diseases and sexually transmitted 
diseases should be included in the centers provided for 
homeless people.
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